Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Optimisation of quality of life in patients with prostate cancer
Prof Heather Payne and Ms Netty Kinsella
Optimisation of quality of life in patients with prostate cancer ( Prof Heather Payne and Ms Netty Kinsella )
11 Dec 2017
Advancements in the diagnosis and treatment of patients with prostate cancer
Prof Heather Payne, Prof Kurt Miller, Ms Netty Kinsella and Prof David Dearnaley
Advancements in the diagnosis and treatment of patients with prostate cancer ( Prof Heather Payne, Prof Kurt Miller, Ms Netty Kinsella and Prof David Dearnaley )
11 Dec 2017
Long term follow up on the ZUMA-1 trial for nHL
Dr Sattva Neelapu - MD Anderson Center, Houston, USA
Long term follow up on the ZUMA-1 trial for nHL ( Dr Sattva Neelapu - MD Anderson Center, Houston, USA )
10 Dec 2017
SABCS 2017: The latest in CDK inhibition in breast cancer
Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz
SABCS 2017: The latest in CDK inhibition in breast cancer ( Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz )
10 Dec 2017
Dexamethasone and the UKALL 2011 trial
Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Dexamethasone and the UKALL 2011 trial ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
9 Dec 2017
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer
Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017
CDK 4/6 inhibitors for older women with HR-positive breast cancer
Harpreet Singh - FDA, USA
CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )
9 Dec 2017
Reducing risk of breast cancer recurrence and death with increased dose density
Prof Richard Gray - University of Oxford, Oxford, UK
Reducing risk of breast cancer recurrence and death with increased dose density ( Prof Richard Gray - University of Oxford, Oxford, UK )
9 Dec 2017
Breast cancer therapy resistance mediated by FGFR amplification
Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA
Breast cancer therapy resistance mediated by FGFR amplification ( Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA )
9 Dec 2017
The REACT trial: Celecoxib vs placebo for primary breast cancer
Prof Charles Coombes - Imperial College School of Medicine, London, UK
The REACT trial: Celecoxib vs placebo for primary breast cancer ( Prof Charles Coombes - Imperial College School of Medicine, London, UK )
9 Dec 2017
Rationale and recruitment in the PARTNER trial
Dr Jean Abraham - University of Cambridge, Cambridge, UK
Rationale and recruitment in the PARTNER trial ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )
9 Dec 2017
CDK 4/6 inhibitors for older women with HR-positive breast cancer
Harpreet Singh - FDA, USA
CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )
8 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation